Coronary artery disease
This should be excluded as the first step in the assessment of dyspepsia. The history is critical, particularly at an unexpected age where congenital coronary abnormality or substance misuse (e.g., amphetamine, cocaine) could be a factor. In making an assessment of dyspepsia, consider that cardiac disorders present with a shorter duration of symptoms (hours, days, or weeks), temporal relationship of symptoms to exertion, and associated features such as dyspnea, weakness, diaphoresis, or altered cardiovascular vital signs. Burning quality of pain and lack of standard risk factors do not exclude cardiac causes.[20]Flook N, Unge P, Agreus L, et al. Approach to managing undiagnosed chest pain: could gastroesophageal reflux disease be the cause? Can Fam Physician. 2007 Feb;53(2):261-6.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17872643
http://www.ncbi.nlm.nih.gov/pubmed/17872643?tool=bestpractice.com
[21]Chang AM, Fischman DL, Hollander JE, et al. Evaluation of chest pain and acute coronary syndromes. Cardiol Clin. 2018 Feb;36(1):1-12.
http://www.ncbi.nlm.nih.gov/pubmed/29173670?tool=bestpractice.com
Diagnostic tests include ECG, serum troponin, exercise stress testing, 99mTc-methoxyisobutyl isonitrile scan, and coronary angiography. Patients suspected of having an acute cardiac problem will need to be assessed to determine the need for urgent intervention to protect threatened cardiac muscle. Such interventions include antiplatelet therapy (aspirin or clopidogrel), anticoagulants such as heparin, thrombolytic therapy, or placement of a coronary artery stent.
Other acute cardiovascular problems that could present with symptoms causing confusion with dyspepsia could include dissecting aortic aneurysm, pericarditis, cardiomyopathy, and, rarely, cardiac arrhythmias.
Upper gastrointestinal malignancy
Malignancy is a rare cause of upper gastrointestinal (UGI) symptoms in primary care;[23]Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment - prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003 Jun 15;17(12):1481-91.
https://onlinelibrary.wiley.com/doi/full/10.1046/j.1365-2036.2003.01646.x?sid=nlm%3Apubmed
http://www.ncbi.nlm.nih.gov/pubmed/12823150?tool=bestpractice.com
however, older patients are far more likely than younger patients to have a neoplasm as the underlying cause for their symptoms. A lower age limit has not been identified that will completely exclude any risk of UGI malignancy; however, the risk of a person <60 years having UGI malignancy is typically very low, even in the presence of an alarm feature.[3]Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013.
https://journals.lww.com/ajg/fulltext/2017/07000/ACG_and_CAG_Clinical_Guideline__Management_of.10.aspx
http://www.ncbi.nlm.nih.gov/pubmed/28631728?tool=bestpractice.com
In the US, endoscopy is suggested for patients ≥60 years to exclude malignancy as the underlying cause of new onset dyspepsia.[3]Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013.
https://journals.lww.com/ajg/fulltext/2017/07000/ACG_and_CAG_Clinical_Guideline__Management_of.10.aspx
http://www.ncbi.nlm.nih.gov/pubmed/28631728?tool=bestpractice.com
In the UK, urgent UGI endoscopy is recommended for those ages 55 years or over with weight loss and dyspepsia.[16]National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Oct 2023 [internet publication].
http://www.nice.org.uk/guidance/ng12
Non-urgent UGI endoscopy should be considered for those ages 55 years or over with:[16]National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Oct 2023 [internet publication].
http://www.nice.org.uk/guidance/ng12
The threshold for investigation should be tailored to local protocols.[3]Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013.
https://journals.lww.com/ajg/fulltext/2017/07000/ACG_and_CAG_Clinical_Guideline__Management_of.10.aspx
http://www.ncbi.nlm.nih.gov/pubmed/28631728?tool=bestpractice.com
[4]Talley NJ, Vakil NB, Moayyedi P. AGA technical review: evaluation of dyspepsia. Gastroenterology. 2005 Nov;129(5):1756-80.
http://www.gastrojournal.org/article/S0016-5085%2805%2901818-4/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/16285971?tool=bestpractice.com
The standard alarm features of serious UGI disease can be remembered by the acronym VBAD:
V: vomiting
B: bleeding or anemia
A: abdominal mass or unintended weight loss
D: dysphagia.
Of patients (mean age 59 years) with alarm features, 3.8% will have UGI malignancy and 12.8% will have complicated disease (i.e., with bleeding, perforation, ischemia, or obstruction) or severe disease.[24]Kapoor N, Bassi A, Sturgess R, et al. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut. 2005 Jan;54(1):40-5.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15591502
http://www.ncbi.nlm.nih.gov/pubmed/15591502?tool=bestpractice.com
These alarm features (particularly when new in onset, persistent, and progressive) along with abnormal abdominal exam (typical of perforation, ischemia, and obstruction) are used to identify those patients who might require additional investigations or interventions.[25]Shaukat A, Wang A, et al. ASGE Standards of Practice Committee. The role of endoscopy in dyspepsia. Gastrointest Endosc. 2015 Aug;82(2):227-32.
https://www.giejournal.org/article/S0016-5107(15)02311-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/26032200?tool=bestpractice.com
Theoretically, alarm features are very sensitive; nearly all patients who have malignancy will have these features when they present for care.[24]Kapoor N, Bassi A, Sturgess R, et al. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut. 2005 Jan;54(1):40-5.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15591502
http://www.ncbi.nlm.nih.gov/pubmed/15591502?tool=bestpractice.com
However, alarm features have poor positive predictive value; most patients with alarm features will not have malignancy.[26]Vakil N, Moayyedi P, Fennerty MB, et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug;131(2):390-401.
http://www.ncbi.nlm.nih.gov/pubmed/16890592?tool=bestpractice.com
Taken alone, alarm features should not cause undue concern.[24]Kapoor N, Bassi A, Sturgess R, et al. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut. 2005 Jan;54(1):40-5.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15591502
http://www.ncbi.nlm.nih.gov/pubmed/15591502?tool=bestpractice.com
[27]Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2004;20(suppl 2):S23-30.
http://www.ncbi.nlm.nih.gov/pubmed/15335410?tool=bestpractice.com
Special attention is required when assessing older patients (>60 years) with new onset (a few months) of progressive symptoms, particularly in the presence of alarm features. The clinician must assess the need to search for malignancy or complicated UGI disease (i.e., with bleeding, perforation, ischemia, or obstruction);[24]Kapoor N, Bassi A, Sturgess R, et al. Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut. 2005 Jan;54(1):40-5.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15591502
http://www.ncbi.nlm.nih.gov/pubmed/15591502?tool=bestpractice.com
[26]Vakil N, Moayyedi P, Fennerty MB, et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology. 2006 Aug;131(2):390-401.
http://www.ncbi.nlm.nih.gov/pubmed/16890592?tool=bestpractice.com
[27]Talley NJ. What the physician needs to know for correct management of gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2004;20(suppl 2):S23-30.
http://www.ncbi.nlm.nih.gov/pubmed/15335410?tool=bestpractice.com
this will often include prompt endoscopy. When evaluating patients with dyspepsia for malignancy or complicated disease, it is important to consider the need for further investigation using UGI endoscopy (preferred), UGI barium contrast radiography, abdominal computed tomography scan, and abdominal ultrasound for selected patients.[5]Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022 Jan 1;117(1):27-56.
https://journals.lww.com/ajg/fulltext/2022/01000/acg_clinical_guideline_for_the_diagnosis_and.14.aspx
http://www.ncbi.nlm.nih.gov/pubmed/34807007?tool=bestpractice.com
[28]American College of Radiology. ACR Appropriateness Criteria®: epigastric pain. Nov 2021 [internet publication].
https://www.acr.org/Clinical-Resources/ACR-Appropriateness-Criteria
[29]American College of Radiology. ACR practice parameter for the performance of esophagrams and upper gastrointestinal examinations in adults. 2024 [internet publication].
https://gravitas.acr.org/PPTS/GetDocumentView?docId=46+&releaseId=2